Centre asks Manufacturers to Indicate Possible Prices of COVID-19 VaccinesAugust 19, 2020 15:19
(Image source from: njbmagazine.com)
India has 3 coronavirus vaccines at three different stages of trials and one among them is in phase 3 stage of human trials.
The central government has asked the vaccine manufacturers to indicate the potential prices of COVID-19 vaccines as soon as they enter the clinical trial stage.
Dr. V K Paul, member of NITI Aayog said that India, at present, has 3 vaccines under production and one of the vaccines is in stage 3 of human trials and the other two are progressing well in phase 1 and phase 2 trials.
V K Paul said that the government is closely reviewing the human trial process of all the three vaccines and is ensuring that the process is taking place in a proper manner.
He added that the outline of the vaccine administration and the supply chain is ready and as and when required detailed and micro level planning for the vaccine administration based on a scientific approach according to the characteristics of the vaccine will be adopted.
Stating that the discussions are in place with the manufacturers, he added that the central government has asked all the manufacturers to come up with a potential price ranger for their coronavirus vaccines being produced.
Pricing is very complex as some of the vaccines are at an early stage of trials. Dr. Paul from NITI Aayog said that they have some insights into what the price range could be but the information on the same from the manufacturers would refine the process as they move forward.
He further stated that already has held discussions with the vaccine manufacturers to know about the facilitations they are expecting.
The government has also directed manufacturers to provide more clear and precise data on their individual production capacities and how could their capacities pan out with time. The government is also actively encouraging the manufacturers to ramp up the capacities with facilitations.
Dr. VK Paul said that India has huge potential and capacity in vaccine manufacturing and will become the leading country in vaccine production.
Earlier on Monday, National Expert group on Vaccine Administration has met the leading domestic manufacturers which are Serum Institute of India, Pune; Bharat Biotech, Hyderabad; Zydus Cadila, Ahmedabad; and Gennova Biopharmaceuticals, Pune; and also Biological E in Hyderabad.
In the meeting, these domestic manufacturers have provided the National Expert Group on Vaccine Administration with some inputs about the various vaccines at various stages being developed by indigenous manufacturers as well their expectations from the Union Government.
Recently, Oxford’s coronavirus vaccine Covishield has also got approval from the Centre to conduct its phase 3 trials in Mumbai’s King George Memorial hospital.
By Gayatri Yellayi